Cooley LLP — China

Andrew Harline

Andrew Harline represents both public and privately-held companies in a wide range of corporate and securities matters, including private financings, mergers and acquisitions and public offerings. He also represents venture capital and private equity funds in connection with financings and other transactions. Andrew is counsel to companies across a broad range of industries and ranging from start-ups to well established companies. · Corporate Law

Christina Zhang

Christina Zhang is partner and chief representative of Cooley's Shanghai office. Christina has more than 20 years of practice experience, gained through private practice and in–house experience in the US and China. Christina represents clients and investment funds in cross border transactions, especially in life sciences and high tech industries. She has represented clients in their financings, licensing and partnership transactions, joint ventures, acquisitions and divestitures, manufacturing, distribution and marketing activities in China and US. · Life Sciences

Jingyi Xu

Jingyi Xu is a partner of Cooley’s fund formation practice. Her practice focuses on the formation and representation of private investment funds both in the United States and internationally. In particular, Jingyi specializes in representing fund managers investing in China in connection with the formation of their USD-dominated funds, including venture capital funds, private equity funds and project funds, as well as upper-tier arrangements, carried interest plans and various governance matters. Jingyi also represents institutional investors (including sovereign wealth funds and funds of funds) and other investors in connection with investments in private funds. · Fund Formation

Jordan Silber

Jordan’s practice is concentrated on the formation and representation of private investment funds – primarily venture capital and growth equity funds – in the US, Greater Asia and Middle East/North Africa regions. Over the last 20 years, he has acted in a leading legal capacity in the raising of more than $100 billion in private fund interests across a multitude of investment areas, primarily focusing on technology, healthcare and life sciences. · Investment Funds

Pang Lee

Pang Lee's practice is focused on the offering, investment and operation of various types of private investment funds, with a focus on venture capital and private equity funds, special situation funds, and investment advisory businesses. He has advised clients on various types of fund formations across a range of geographies and industries, particularly for fund managers and institutional investors making investments in and around the Pacific Rim, with an emphasis on Greater China, South and Southeast Asia and the Silicon Valley. Pang also has experience advising clients on secondary transactions, co-investments and strategic joint venture arrangements. Pang brings a global perspective, having started his career as a private funds lawyer in New York, and have also practiced in the San Francisco and Shanghai offices of Cooley. Pang regularly speaks at regional industry conferences in China and Southeast Asia. · Investment Funds

Patrick Loofbourrow

Patrick is a co-founder of Cooley’s Shanghai and Singapore offices and splits his time across Cooley’s Asia and California offices. Patrick's practice focuses on the representation of high-growth emerging technology and life sciences companies as well as venture capital and other firms that invest in those companies across Asia and the US. Concentrating on corporate and securities law, he has counseled company clients and investors in a wide variety of projects, including company formations, spin-offs, private and public financings, initial public offerings, mergers and acquisitions, joint venture and other strategic transactions, employee equity incentives, corporate governance matters and SEC reporting and compliance. Patrick counsels companies in a variety of industries, including fintech, ecommerce, edtech, software, digital health, biotechnology, healthcare and medical devices. · Corporate Law

Xun Zeng

Xun Zeng is an investment funds partner of Cooley’s Beijing office. Her practice focuses on the formation, structuring and operation of a wide variety of investment funds, including venture capital, private equity, hybrid and co-investment funds. She advises fund sponsors on the marketing, formation and operation of their funds, as well as upper-tier arrangements, carried interest plans, strategic joint venture arrangements and various governance matters. Xun also has extensive experience in representing institutional investors in connection with investments in private funds. · Investment Funds

Yiming Liu

Yiming Liu represents companies and investment funds on strategic transactions in the life sciences and technology industries. Yiming regularly advises clients on the structuring, negotiation and documentation of a wide range of cross-border transactions, including mergers and acquisitions, private equity investments, venture financings, joint ventures, licensing and collaboration arrangements. In addition, Yiming is widely recognized for his work on life sciences and healthcare IPOs in Hong Kong and the US. In particular, he is adept in leading the compilation of offering documents and the communications with issuers, underwriters, investors and regulators during the listing processes. With advanced degrees in molecular, cellular and developmental biology and health services administration, Yiming leverages his technical background to help clients achieve their desired results. · Mergers and Acquisitions